Home/Investors/Access Biotechnology

Access Biotechnology

Biotech Investor · 8 portfolio companies

Portfolio

8

Focus Areas

8

Top Stage

phase-1

Investment Focus

Oncology Neuroscience Immunology Autoimmune Diseases Respiratory Neuropsychiatry Major Depressive Disorder Metabolic

Portfolio Companies

Company	Stage	Valuation	Focus
Auron Therapeutics	phase-1	—	Oncology
Arialys Therapeutics	phase-1	—	Neuroscience, Immunology
Delphia Therapeutics	preclinical	—	Oncology
Matchpoint Therapeutics	preclinical	—	Immunology
Areteia Therapeutics	phase-3	—	Respiratory, Immunology
Draig Therapeutics	Phase 2	—	Neuropsychiatry, Major Depressive Disorder
Jnana Therapeutics	phase-1	—	Immunology, Metabolic
Nido Biosciences	preclinical	—	Neuroscience, Immunology

Frequent Co-Investors

Atlas Venture3 shared Sanofi Ventures2 shared Cormorant Asset Management1 shared 5AM Ventures1 shared Versant Ventures1 shared GV1 shared SV Health Investors1 shared Droia Ventures1 shared